
Semaglutide’s Impact on Dental Health in American Males: A Five-Year Study
Reading Time: 3 minutes Introduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been increasingly prescribed for the management of type 2 diabetes and obesity. While its metabolic benefits are well-documented, the long-term effects on other aspects of health, particularly oral health, have garnered attention. This article delves into a five-year longitudinal study that examines the impact of semaglutide on dental health in American males, providing insights crucial for healthcare providers and patients alike. Study Design and Methodology The longitudinal study involved a cohort of 500 American males aged between 30 and 65, diagnosed with type 2 diabetes and prescribed semaglutide. Participants underwent comprehensive...